{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:57:24Z","timestamp":1781351844024,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7242075"],"award-info":[{"award-number":["7242075"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.exphem.2026.105427","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:33:04Z","timestamp":1775057584000},"page":"105427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serum cholesterol levels demonstrate dynamic changes following autologous hematopoietic stem cell transplantation in patients with multiple myeloma"],"prefix":"10.1016","volume":"159","author":[{"given":"Yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-033X","authenticated-orcid":false,"given":"Weikai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2026.105427_bib0001","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.exphem.2026.105427_bib0002","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1200\/EDBK_159009","article-title":"Updated diagnostic criteria and staging system for multiple myeloma","volume":"35","author":"Rajkumar","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.exphem.2026.105427_bib0003","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2026.105427_bib0004","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S1470-2045(20)30756-7","article-title":"Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group","volume":"22","author":"Moreau","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.exphem.2026.105427_bib0005","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1586\/17474086.2015.1078236","article-title":"Clinical treatment of newly diagnosed multiple myeloma","volume":"8","author":"Cejalvo","year":"2015","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.exphem.2026.105427_bib0006","doi-asserted-by":"crossref","first-page":"34329","DOI":"10.18632\/oncotarget.6020","article-title":"Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.exphem.2026.105427_bib0007","doi-asserted-by":"crossref","first-page":"eaau9087","DOI":"10.1126\/scitranslmed.aau9087","article-title":"Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease","volume":"11","author":"Liu","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2026.105427_bib0008","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.2021013832","article-title":"Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins","volume":"139","author":"Panaroni","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2026.105427_bib0009","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1038\/onc.2015.464","article-title":"Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax","volume":"35","author":"Bajpai","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2026.105427_bib0010","first-page":"181","article-title":"[Plasma lipoproteins and multiple myeloma. Variations of lipid constituents of HDL and apolipoproteins A1 and B]","volume":"43","author":"Hachem","year":"1983","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.exphem.2026.105427_bib0011","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1530\/JOE-16-0657","article-title":"High-density lipoprotein (HDL) metabolism and bone mass","volume":"233","author":"Papachristou","year":"2017","journal-title":"J Endocrinol"},{"key":"10.1016\/j.exphem.2026.105427_bib0012","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.7150\/jca.31357","article-title":"Identification of high serum apolipoprotein A1 as a favorable prognostic indicator in patients with multiple myeloma","volume":"10","author":"Liang","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.exphem.2026.105427_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1034037","article-title":"Prognostic significance of pretreatment apolipoprotein A-I as a noninvasive biomarker in cancer survivors: a meta-analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"Dis Markers"},{"key":"10.1016\/j.exphem.2026.105427_bib0014","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1158\/0008-5472.CAN-17-0165","article-title":"Nature and nurture: what determines tumor metabolic phenotypes?","volume":"77","author":"Mayers","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.exphem.2026.105427_bib0015","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4103\/0366-6999.155112","article-title":"Proteomic analysis for finding serum pathogenic factors and potential biomarkers in multiple myeloma","volume":"128","author":"Zhang","year":"2015","journal-title":"Chin Med"},{"key":"10.1016\/j.exphem.2026.105427_bib0016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00280-003-0692-y","article-title":"Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease","volume":"53","author":"Hungria","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.exphem.2026.105427_bib0017","first-page":"2359","article-title":"[Hypocholesterolemia in multiple myeloma. Inverse relation to the component M and the clinical stage]","volume":"74","author":"Scolozzi","year":"1983","journal-title":"Minerva Med"},{"key":"10.1016\/j.exphem.2026.105427_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.638288","article-title":"The lipoprotein transport system in the pathogenesis of multiple myeloma: advances and challenges","volume":"11","author":"Lazaris","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.exphem.2026.105427_bib0019","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/CS20080106","article-title":"High-density lipoproteins, inflammation and oxidative stress","volume":"116","author":"Tabet","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.exphem.2026.105427_bib0020","first-page":"221","article-title":"[Chinese guidelines for lipid management (2023)]","volume":"51","year":"2023","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.exphem.2026.105427_bib0021","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bbamem.2007.03.026","article-title":"Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies","volume":"1768","author":"Zidovetzki","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.exphem.2026.105427_bib0022","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2013.03.021","article-title":"A comprehensive machine-readable view of the mammalian cholesterol biosynthesis pathway","volume":"86","author":"Mazein","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.exphem.2026.105427_bib0023","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","article-title":"Cholesterol metabolism and homeostasis in the brain","volume":"6","author":"Zhang","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.exphem.2026.105427_bib0024","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12929-016-0256-1","article-title":"The genetics and screening of familial hypercholesterolaemia","volume":"23","author":"Henderson","year":"2016","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.exphem.2026.105427_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002364","article-title":"An interferon regulated microRNA provides broad cell-intrinsic antiviral immunity through Multihit host-directed targeting of the sterol Pathway","volume":"14","author":"Robertson","year":"2016","journal-title":"PLos Biol."},{"key":"10.1016\/j.exphem.2026.105427_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000598","article-title":"Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis","volume":"9","author":"Blanc","year":"2011","journal-title":"PLos Biol"},{"key":"10.1016\/j.exphem.2026.105427_bib0027","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(06)69044-2","article-title":"Cholesterol gallstone disease","volume":"368","author":"Portincasa","year":"2006","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.exphem.2026.105427_bib0028","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1752-0509-6-130","article-title":"A whole-body mathematical model of cholesterol metabolism and its age-associated dysregulation","volume":"6","author":"Mc Auley","year":"2012","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.exphem.2026.105427_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/boneres.2016.41","article-title":"Vitamin D, calcium homeostasis and aging","volume":"4","author":"Veldurthy","year":"2016","journal-title":"Bone Res"},{"key":"10.1016\/j.exphem.2026.105427_bib0030","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/eurheartj\/ehad371","article-title":"Lipid distributions in the Global Diagnostics Network across five continents","volume":"44","author":"Martin","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.exphem.2026.105427_bib0031","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00277-007-0375-6","article-title":"Cholesterol levels in patients with multiple myeloma","volume":"87","author":"Yavasoglu","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2026.105427_bib0032","first-page":"838","article-title":"[Alteration and significance of serum lipid levels and nutritional status during BCMA-CAR-T-cell therapy in patients with refractory or relapsed multiple myeloma: a retrospective study based on LEGEND-2]","volume":"44","author":"Xu","year":"2023","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.exphem.2026.105427_bib0033","first-page":"675","article-title":"[The influence of apolipoprotein A1 on the prognosis of multiple myeloma]","volume":"41","author":"Shen","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.exphem.2026.105427_bib0034","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1200\/JCO.2016.68.3482","article-title":"Statins are associated with reduced mortality in multiple myeloma","volume":"34","author":"Sanfilippo","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2026.105427_bib0035","doi-asserted-by":"crossref","unstructured":"Branvall E, Ekberg S, Eloranta S, Wasterlid T, Birmann BM, Smedby KE. Statin use is associated with improved survival in multiple myeloma: a Swedish population-based study of 4315 patients. 2020;95:652\u2013661. doi:10.1002\/ajh.25778","DOI":"10.1002\/ajh.25778"},{"key":"10.1016\/j.exphem.2026.105427_bib0036","doi-asserted-by":"crossref","first-page":"e937","DOI":"10.1016\/j.clml.2020.07.003","article-title":"Statins reduce mortality in multiple myeloma: a population-based US study","volume":"20","author":"Afzal","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.exphem.2026.105427_bib0037","doi-asserted-by":"crossref","unstructured":"Schmidmaier R, Baumann P, Bumeder I, Meinhardt G, Straka C, Emmerich B. First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma. 2007;79:240\u2013243. doi:10.1111\/j.1600-0609.2007.00902.x","DOI":"10.1111\/j.1600-0609.2007.00902.x"},{"key":"10.1016\/j.exphem.2026.105427_bib0038","doi-asserted-by":"crossref","unstructured":"Sondergaard TE, Pedersen PT, Andersen TL, et al. A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma. 2009;27:17\u201322. doi:10.1002\/hon.869","DOI":"10.1002\/hon.869"},{"key":"10.1016\/j.exphem.2026.105427_bib0039","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00277-011-1276-2","article-title":"Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma","volume":"90","author":"Hus","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2026.105427_bib0040","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.3390\/nu15122722","article-title":"Vitamin D intake, serum 25-hydroxyvitamin-D (25(OH)D) levels, and cancer risk: a comprehensive meta-meta-analysis including meta-analyses of randomized controlled trials and observational epidemiological studies","volume":"15","author":"Arayici","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.exphem.2026.105427_bib0041","first-page":"175","article-title":"Vitamin D and liver cancer risk: a meta-analysis of prospective studies","volume":"29","author":"Guo","year":"2020","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.exphem.2026.105427_bib0042","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/ijerph14020127","article-title":"25-Hydroxyvitamin D status and risk for colorectal cancer and type 2 diabetes mellitus: a systematic review and meta-analysis of epidemiological studies","volume":"14","author":"Ekmekcioglu","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.exphem.2026.105427_bib0043","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/nu14071448","article-title":"Vitamin D and cancer: an historical overview of the epidemiology and mechanisms","volume":"14","author":"Munoz","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.exphem.2026.105427_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1157969","article-title":"Vitamin D deficiency linked to abnormal bone and lipid metabolism predicts high-risk multiple myeloma with poorer prognosis","volume":"14","author":"Bao","year":"2023","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.exphem.2026.105427_bib0045","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.1007\/s11033-020-05854-0","article-title":"VD(3) and LXR agonist (T0901317) combination demonstrated greater potency in inhibiting cholesterol accumulation and inducing apoptosis via ABCA1-CHOP-BCL-2 cascade in MCF-7 breast cancer cells","volume":"47","author":"Munir","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.exphem.2026.105427_bib0046","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jsbmb.2012.12.019","article-title":"1,25(OH)2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism in type 2 diabetic patients","volume":"136","author":"Riek","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.exphem.2026.105427_bib0047","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.6004\/jnccn.2023.0061","article-title":"Multiple myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Kumar","year":"2023","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26000603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26000603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:26:07Z","timestamp":1781349967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X26000603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":47,"alternative-id":["S0301472X26000603"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105427","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum cholesterol levels demonstrate dynamic changes following autologous hematopoietic stem cell transplantation in patients with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Experimental Hematology.","name":"copyright","label":"Copyright"}],"article-number":"105427"}}